Mitomycin_C-loaded_microcapsules_in_the_treatment_of_colorectal_liver_metastases._Pharmacokinetics_of_regionally_administered_particulate_chemotherapy._Microencapsulated_mitomycin_C_has_been_used_for_the_treatment_of_intrahepatic_tumors_in_Japan,_but_there_have_been_no_reports_of_its_use_in_western_countries._In_this_study,_the_pharmacokinetic_profile_of_intrahepatic_arterial_mitomycin_C_microcapsules_is_reported._Regional_mitomycin_C_was_administered_to_six_patients,_both_in_the_microencapsulated_form_and_in_solution._The_clearance_(140_+/-_31_1/hour,_mean_+/-_SD)_and_half-life_of_drug_in_plasma_(0.39_+/-_0.03_hours),_and_volume_distribution_(246_+/-_23_1)_were_significantly_higher,_and_peak_drug_concentrations_(80_+/-_75_ng/ml)_significantly_lower_with_the_microencapsulated_preparation_than_with_the_free_drug_(clearance,_46_+/-_8_1/hour;_half-life,_0.11_+/-_0.02_hours;_volume_distribution,_33_+/-_4;_peak_drug_concentration,_812_+/-_423_ng/ml),_on_Student's_t_testing_(P_less_than_0.05)._The_results_show_that_very_little_systemic_exposure_is_associated_with_the_microencapsulated_form_of_mitomycin_C._Dose_escalation_should_be_feasible_without_increasing_systemic_toxicity.